IRIS
TOMELLERI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 338
NA - Nord America 277
AS - Asia 159
AF - Africa 2
Totale 776
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 276
SE - Svezia 159
IT - Italia 92
CN - Cina 66
RU - Federazione Russa 47
SG - Singapore 47
PH - Filippine 18
DE - Germania 13
FI - Finlandia 12
IN - India 11
IE - Irlanda 4
IR - Iran 4
MK - Macedonia 4
KR - Corea 3
ES - Italia 2
GB - Regno Unito 2
HK - Hong Kong 2
JP - Giappone 2
MY - Malesia 2
TR - Turchia 2
AL - Albania 1
CA - Canada 1
DZ - Algeria 1
ID - Indonesia 1
IL - Israele 1
NL - Olanda 1
TG - Togo 1
UA - Ucraina 1
Totale 776
Salva come PNG Salva come JPEG
Città #
Shanghai 53
Ashburn 36
Lawrence 31
Princeton 31
New York 30
Boardman 29
Singapore 26
Milan 21
Moscow 21
Helsinki 11
Makati City 9
Pune 9
Naples 8
Rome 8
Los Angeles 6
Verona 5
Vittoria 5
Dublin 4
Goito 4
Quezon City 4
Cabanatuan City 3
Osimo 3
Pisa 3
Skopje 3
Ancona 2
Ankara 2
Arnsberg 2
Barcelona 2
Castel Mella 2
Clifton 2
Erlangen 2
Falkenstein 2
Florence 2
Foshan 2
Honcho 2
Hyderabad 2
Orani 2
Padova 2
Petaling Jaya 2
Santa Clara 2
Seattle 2
Washington 2
York 2
Zhengzhou 2
Amsterdam 1
Arlington 1
Atlanta 1
Catania 1
Giv‘atayim 1
Issogne 1
Jakarta 1
Lappeenranta 1
Lomé 1
Martina Franca 1
Sacramento 1
Sezze 1
Tirana 1
Toronto 1
Trentola-Ducenta 1
Vaprio d'Adda 1
Totale 419
Salva come PNG Salva come JPEG
Nome #
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial 44
Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series 36
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 33
Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease 31
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 27
Interleukin 1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study 27
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 25
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study 24
DRUG RETENTION RATES OF BIOLOGICAL AGENTS IN ADULT ONSET STILL'S DISEASE IN THE PRE-CANAKINUMAB ERA 24
A Prospective Observational Study on the Efficacy and Safety of Infliximab-Biosimilar (CT-P13) in Patients With Takayasu Arteritis (TAKASIM) 22
Cardiac magnetic resonance findings in acute and post-acute COVID-19 patients with suspected myocarditis 21
Canakinumab injection for the treatment of active Still’s disease, including adult-onset Still’s disease 21
Efficacy and improved tolerability of combination therapy with interleukin-1 blockade and MAPK pathway inhibitors for the treatment of Erdheim-Chester disease 20
Drug retention rates of biological agents in adult onset Still's disease 20
Efficacy and safety of apremilast for Behçet's syndrome: a real-life single-centre Italian experience 19
Clinically isolated aortitis successfully treated with methotrexate monotherapy 19
An enlightening scan 18
Drug retention and discontinuation reasons between seven biologics in patients with Takayasu arteritis 18
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study 18
Tocilizumab for the Treatment of Myocardial Inflammation Shown by Cardiac Magnetic Resonance: Report of Two Cases and Rationale for Its Therapeutic Use 17
GM-CSF blockade with mavrilimumab in severe COVID-19 pneumonia and systemic hyperinflammation: a single-centre, prospective cohort study 17
Oncogene-induced maladaptive activation of trained immunity in the pathogenesis and treatment of Erdheim-Chester disease 17
Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production 16
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review 16
Primary heart involvement in systemic sclerosis, from conventional to innovative targeted therapeutic strategies 16
null 15
Response to: 'Correspondence on Impact of COVID-19 pandemic on patients with large-vessels vasculitis in Italy: A monocentric survey' by Comarmond et al 15
Efficacy and Safety of Methotrexate for the Treatment of Autoimmune Virus-Negative Myocarditis: A Case Series 15
Successful use of cyclosporin A and interleukin-1 blocker combination therapy in VEXAS syndrome: a single-center case series 14
Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic 14
Impact of COVID-19 pandemic on patients with large-vessel vasculitis in Italy: A monocentric survey 13
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation 13
Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors 12
Failure of first anti-TNF agent in Takayasu’s arteritis: To switch or to swap? 12
Myocarditis as a manifestation of Erdheim–Chester Disease: successful use of anti- IL1 and BRAF inhibitor combination therapy 12
Interleukin-1 and Systemic Sclerosis: Getting to the Heart of Cardiac Involvement 12
LONG-TERM PATHOPHYSIOLOGIC AND PROGNOSTIC EVALUATION OF DIFFERENT DISEASE SUBSETS IN GIANT CELL ARTERITIS 11
Clinical and dermoscopic description of accelerated nodulosis after tocilizumab treatment for an isolated aortitis with coronary involvement 11
Large Vessel Vasculitis Affecting the Aorta and Its Branches in Relapsing Polychondritis: Case Series and Systematic Review of the Literature 11
Living with fibromyalgia during the COVID-19 pandemic: mixed effects of prolonged lockdown on the well-being of patients 11
Tocilizumab for the Treatment of Myocardial Inflammation Shown by Cardiac Magnetic Resonance 11
Successful use of ixekizumab for glucocorticoid-free remission maintenance in giant cell arteritis 10
Effectiveness and safety of infliximab dose escalation in patients with refractory Takayasu arteritis: A real-life experience from a monocentric cohort 9
Efficacy of interleukin-1 blockade with anakinra in the management of post-COVID-19 steroid-dependent multisystem inflammatory syndrome: a case report 9
Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation – Authors' reply 9
Cardiovascular involvement in Erdheim-Chester diseases is associated with myocardial fibrosis and atrial dysfunction 9
Efficacy and safety of TNF-α antagonists and tocilizumab in Takayasu arteritis: multicentre retrospective study of 209 patients 8
Patients' experience and tolerability with canakinumab and anakinra for the treatment of adult-onset Still's disease 8
The target on B cells in Systemic Sclerosis: a “midsummer dream” to extinguish inflammation and prevent early disease progression to fibrosis 8
Potential acceptance of COVID-19 vaccine in rheumatological patients: A monocentric comparative survey 8
One year later: The case of tocilizumab in COVID-19 7
Giant cell arteritis: Update on clinical manifestations, diagnosis, and management 7
Presenting features and outcomes of cranial-limited and large-vessel giant cell arteritis: a retrospective cohort study 7
Myocardial infarction in giant cell arteritis: It is all a matter of balance 7
Impact of Geographic Location on Diagnosis and Initial Management of Takayasu Arteritis: A Tale of Two Cohorts from Italy and India 7
Effectiveness of a two-year tapered course of tocilizumab in patients with giant cell arteritis: A single-centre prospective study 5
Multimodal chorioretinal imaging in erdheim-chester disease 5
Spontaneous coronary-artery dissection 3
Case report: Cytopenias in VEXAS syndrome - a WHO 2022 based approach in a single-center cohort 2
High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation 1
Totale 897
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.478
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.478
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202014 1 0 0 0 0 0 0 0 0 0 12 1
2020/202121 1 0 2 3 0 4 3 3 0 0 3 2
2021/202264 0 0 23 17 2 4 6 2 4 3 0 3
2022/2023305 75 58 15 3 8 36 29 38 19 10 9 5
2023/2024403 11 30 52 36 34 59 33 44 3 7 15 79
2024/202589 89 0 0 0 0 0 0 0 0 0 0 0
Totale 897